Coronary artery bypass graft market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2024-2031).Coronary artery bypass graft surgery (CABG) is done to treat a blockage or narrowing of 1 or more of the coronary arteries. It can restore the blood supply to heart muscle when nonsurgical procedures are not a choice.
Market Dynamics
Increased myocardial infarction lead the growth of the market
The market is growing due to increased myocardial infarction, an increasing geriatric population, and a favorable reimbursement scenario. According to the national library of Medicine estimate, myocardial infarction accounts for 3 million lives globally. In addition, as per the estimates of the United Nations, the geriatric population is expected to double by 2.1 billion in 2050. The geriatric population is more prone to cardiovascular diseases as fat deposits build up over the wall of arteries over a period of time. Moreover, a favorable reimbursement scenario is also positively influencing the market growth.
Increase in Demand for Robotic Surgeries
Robot- assisted surgeries allow surgeons to perform complex procedures with more precision there these are minimally invasive surgeries that are less risky and have a smaller surgical cuts . Minimally invasive coronary artery bypass graft surgery ensures fewer incisions, reduced hospitalization period, less blood loss, and high surgical accuracy.Thus, surgeons are increasingly preferring minimally invasive procedures to enhance accuracy and ensure patient safety.Development of healthcare facilities in emerging countries is augmenting the availability of coronary artery disease surgical treatment thereby fostering the coronary artery bypass graft market growth.Public healthcare organizations and governmnets are investing significantly in the improvement of healthcare infrastructure to meet the surging demand for advanced treatments for coronary disease. For instance, Million hearts, a national initiative by the Department of Health & Human Services, aims to prevent one million heart attacks and strokes within five years.
Market Segmentation
Our in-depth analysis of the global coronary artery bypass graftmarket includes the following segments by technology, surgical procedure, and end users:
Off-Pump CABG is Projected to Emerge as the Largest Segment
Based on the technology, the global coronary artery bypass graftmarket is sub-segmented into off-pump cabg, on-pump cabg, and minimally invasive direct. Among these, the off-pump sub-segment is expected to hold the largest share of the market. This growth can be attributed to benefits associated with the method, such as shorter hospital stays, smaller incisions, and faster recovery. In addition, it also reduces the risk of various postsurgical conditions such as infection, arrhythmia, infection, and inflammation. Moreover, it offers better options to patients with cirrhosis, chronic lung conditions, and kidney problems.
Hospital Sub-segment to Hold a Considerable Market Share
The hospital segment dominated the market in 2023.This can be attributed to technological advancements that aid in treating complex medical conditions at hospitals. The hospitals have a wide range of access to diagnostic equipment that aids in treating chronic conditions. Thus, the mentioned factor is contributing to growth for the segment. In addition, the presence of major hospitals such as Cleveland Clinic contributes to the higher share of the segment. Cleveland Clinic consistently ranks among the best hospital systems in the world and the US, and it is especially well-regarded regarding technical management systems.
Regional Outlook
The globalcoronary artery bypass graftmarket is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America). Asia-Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors, such as the increasing geriatric population in India and China. As per the estimates of WHO, by 2040, an estimated 402 million of the total population in China will be more than 60 years. These countries also have a high rate of coronary heart disease (CHD) mortality. Thus, above mentioned factors are contributing to the growth of the market.
Global Coronary Artery Bypass Graft Market Growth by Region 2024-2031
North America Holds Major Market Share
Among all the regions, North America holds a significant share and it is expected to continue its stronghold throughout the forecast period. The major factors attributing to the growth are a steep rise in the global prevalence of multiple cardiovascular indications like coronary artery diseases, strokes, and atrial fibrillation due to the rise in lifestyle-related diseases such as diabetes and obesity necessitating the CABG procedures and thus, a rise in demand for surgical grafts and devices.The available statistics show that there is a burden of coronary heart disease (CHD) in North America, especially in the US. For instance, according to the July 2022 update by CDC, 20.1 million Americans aged 20 years and older were affected by CHD in 2020. Additionally, as per the same source, every year nearly about 805,000 Americans experience a heart attack. Thus, the increasing incidence of heart disease requires CABG procedures for patient survival. Thus, the growing prevalence of heart diseases and other cardiac disorders is expected to contribute to the studied market growth in the region.
Market Players Outlook
*Note: Major Players Sorted in No Particular Order.
The major companies serving the global coronary artery bypass graft market include Getinge, Medtronic, Peters Surgical. and Terumo Medical Corp.,among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in February 2023, KimalPLC unveiled a strategic collaboration with Marizyme, Inc. to promote DuraGraft, the company's flagship product designed to prevent ischemia-reperfusion injury, a key factor in vein graft disease.
The Report Covers
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Getinge AB
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Medtronic Plc
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Peters Surgical
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Terumo Medical Corp.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
4. Market Segmentation
4.1. Global Coronary Artery Bypass Graft Market by Technology
4.1.1. Off-pump CABG
4.1.2. On-pump CABG
4.1.3. Minimally Invasive Direct
4.2. Global Coronary Artery Bypass Graft Market by Surgical Procedure
4.2.1. Single CABG Surgery
4.2.2. Double CABG Surgery
4.2.3. Triple CABG Surgery
4.2.4. Quadruple CABG Surgery
4.3. Global Coronary Artery Bypass GraftMarket by End Users
4.3.1. Hospitals
4.3.2. Cardiology Clinics
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East & Africa
6. Company Profiles
6.1. Boston Scientific Corp.
6.2. Edwards Lifesciences Corp.
6.3. Genesee Biomedical Inc.
6.4. Guidant Group
6.5. KARL STORZ GmbH & Co. KG
6.6. MAQUET Holding B.V. & Co.KG
6.7. NeoGraftTechnologies.Inc
6.8. Novadaq Technologies Inc.
6.9. Scanlan International
6.10. Sorin Group
6.11. Stryker Corp.
6.12. Teleflex Inc.
1. GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
2. GLOBAL OFF-PUMPCORONARY ARTERY BYPASS GRAFT MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
3. GLOBAL ON-PUMPCORONARY ARTERY BYPASS GRAFT MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
4. GLOBALMINIMALLY INVASIVE DIRECTCORONARY ARTERY BYPASS GRAFT MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
5. GLOBALCORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY SURGICAL PROCEDURE, 2023-2031 ($ MILLION)
6. GLOBAL SINGLECORONARY ARTERY BYPASS GRAFT SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
7. GLOBAL DOUBLECORONARY ARTERY BYPASS GRAFT SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
8. GLOBALTRIPLECORONARY ARTERY BYPASS GRAFT SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
9. GLOBALQUADRUPLE CORONARY ARTERY BYPASS GRAFT SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
10. GLOBAL CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY END USERS, 2023-2031 ($ MILLION)
11. GLOBAL CORONARY ARTERY BYPASS GRAFT BY HOSPITALSMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
12. GLOBAL CORONARY ARTERY BYPASS GRAFT BYCARDIOLOGY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
13. GLOBAL CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
14. NORTH AMERICAN CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
15. NORTH AMERICAN CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
16. NORTH AMERICAN CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY SURGICAL PROCEDURE, 2023-2031 ($ MILLION)
17. NORTH AMERICAN CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY END USERS,2023-2031 ($ MILLION)
18. EUROPEAN CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
19. EUROPEAN CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
20. EUROPEAN CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY SURGICAL PROCEDURE, 2023-2031 ($ MILLION)
21. EUROPEAN CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY END USERS, 2023-2031 ($ MILLION)
22. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
23. ASIA-PACIFICCORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
24. ASIA-PACIFICCORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY SURGICAL PROCEDURE, 2023-2031 ($ MILLION)
25. ASIA-PACIFICCORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY END USERS, 2023-2031 ($ MILLION)
26. REST OF THE WORLD CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
27. REST OF THE WORLD CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
28. REST OF THE WORLD CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY SURGICAL PROCEDURE, 2023-2031 ($ MILLION)
29. REST OF THE WORLD CORONARY ARTERY BYPASS GRAFTMARKET RESEARCH AND ANALYSIS BY END USERS, 2023-2031 ($ MILLION)
1. GLOBALCORONARY ARTERY BYPASS GRAFT MARKET SHARE BY TECHNOLOGY, 2023 VS 2031 (%)
2. GLOBAL OFF-PUMPCORONARY ARTERY BYPASS GRAFT MARKET SHARE BY REGION, 2023 VS 2031 (%)
3. GLOBALON-PUMPCORONARY ARTERY BYPASS GRAFTMARKET SHARE BY REGION, 2023 VS 2031 (%)
4. GLOBALMINIMALLY INVASIVE DIRECT CORONARY ARTERY BYPASS GRAFT MARKET SHARE BY REGION, 2023 VS 2031 (%)
5. GLOBALCORONARY ARTERY BYPASS GRAFTMARKET SHARE BY SURGICAL PROCEDURE, 2023 VS 2031 (%)
6. GLOBALSINGLE CORONARY ARTERY BYPASS GRAFT SURGERY MARKET SHARE BY REGION, 2023 VS 2031 (%)
7. GLOBALDOUBLECORONARY ARTERY BYPASS GRAFT SURGERYMARKET SHARE BY REGION, 2023 VS 2031 (%)
8. GLOBALTRIPLECORONARY ARTERY BYPASS GRAFT SURGERYMARKET SHARE BY REGION, 2023 VS 2031 (%)
9. GLOBAL QUADRUPLE CORONARY ARTERY BYPASS GRAFT SURGERY MARKET SHARE BY REGION, 2023 VS 2031 (%)
10. GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET SHARE BY END USERS, 2023 VS 2031 (%)
11. GLOBAL CORONARY ARTERY BYPASS GRAFT BY HOSPITALSMARKET SHARE BY REGION, 2023 VS 2031 (%)
12. GLOBAL CORONARY ARTERY BYPASS GRAFT BYCARDIOLOGY CLINICS MARKET SHARE BY REGION, 2023 VS 2031 (%)
13. GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET SHARE BY REGION, 2023 VS 2031 (%)
14. US CORONARY ARTERY BYPASS GRAFTMARKET SIZE, 2023-2031 ($ MILLION)
15. CANADA CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
16. UK CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
17. FRANCE CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
18. GERMANY CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
19. ITALY CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
20. SPAIN CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
21. REST OF EUROPE CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
22. INDIA CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
23. CHINA CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
24. JAPAN CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
25. SOUTH KOREA CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
26. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
27. LATIN AMERICACORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)
28. MIDDLE EAST AND AFRICACORONARY ARTERY BYPASS GRAFT MARKET SIZE, 2023-2031 ($ MILLION)